Creating Value for Life Science Research!


Get a Free Sample of this product!
shopping cart image

Recombinant Human MIG (CXCL9)



Catalog Number : 300-26

Description

MIG, a CXC chemokine, is produced by IFN stimulated monocytes, macrophages and endothelial cells. It signals through the CXCR3 receptor. MIG selectively chemoattracts Th1 lymphocytes, and also exerts other activities including inhibition of tumor growth, angiogenesis, and inhibition of colony formation of hematopoietic progenitors. Human MIG is active on murine cells. Recombinant human MIG is an 11.7 kDa protein containing 103 amino acid residues, including the four highly conserved cysteine residues present in CXC chemokines.

Additional Information

Source:
E. Coli
 
Purity:
Above 98% as determined by SDS-PAGE Analysis.
 
Cross Reactivity:
NULL
 
Biological Activity
Determined by its ability to chemoattract human peripheral blood T lymphocytes using a concentration range of 10.0-100.0 ng/ml.
 
AA Sequence
TPVVRKGRC SCISTNQGT IHLQSLKDL KQFAPSPSC EKIEIIATL KNGVQTCLN PDSADVKEL IKKWEKQVS QKKKQKNGK KHQKKKVLK VRKSQRSRQ KKTT
Research Interest: Innate Immunity, Angiogenesis, Inflammation
Cell Type: Monocytes and Macrophages
Protein Cross Reactivity: NULL

Availability: In stock

Size Price Qty
5µg
$80.00
20µg
$195.00
100µg
$600.00
500µg
$1,800.00
1mg
$3,000.00